Skip to main content
SILENCE THERAPEUTICS logo SILENCE THERAPEUTICS logo
contact
  • About us
  • Pipeline
  • Our technology
  • Investors
    • Regulatory announcements
    • Events & presentations
    • Share information
      • Share quote
      • Share chart
      • Investment calculator
      • Historical lookup
      • Shareholder information
      • Analyst coverage & key advisers
    • Financials
      • Half year results
      • Annual reports
      • SEC filings
    • Governance
      • Executive Leadership Team
      • Board of directors
      • Governance documents
    • AIM Rule 26
    • Resources
      • Investor FAQs
      • Information request form
      • Investor email alerts
      • Investor contacts
  • News & media
  • Elevated Lp(a) eBook

Shareholder information

Shareholder information

LSE NASDAQ
  • About us
  • Pipeline
  • Our technology
  • Investors
    • Regulatory announcements
    • Events & presentations
    • Share information
      • Share quote
      • Share chart
      • Investment calculator
      • Historical lookup
      • Shareholder information
      • Analyst coverage & key advisers
    • Financials
      • Half year results
      • Annual reports
      • SEC filings
    • Governance
      • Executive Leadership Team
      • Board of directors
      • Governance documents
    • AIM Rule 26
    • Resources
      • Investor FAQs
      • Information request form
      • Investor email alerts
      • Investor contacts
  • News & media
  • Elevated Lp(a) eBook

Shareholder information and documents

Download item year list
Download Description
Notice of General Meeting July 2020 (opens in new window)
1.13 MB
Notice of Annual General Meeting 2020 (opens in new window)
704 KB
Notice of Annual General Meeting 2019 (opens in new window)
689 KB
Notice of Annual General Meeting 2018 (opens in new window)
101 KB
Notice of Annual General Meeting 2017 (opens in new window)
67 KB

Constitutional documents

Download item year list
Download Description
Full Articles of Association (opens in new window)
402 KB
Most Recent AIM Admission Document (opens in new window)
836 KB

Contact us

Investor contact

Gem Hopkins
Head of IR & Corporate Communications
IR@silence-therapeutics.com

Quick links

  • SEC Filings
  • Investor FAQs
  • Information Request Form

Investor email alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Silence Therapeutics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Silence Therapeutics to send you the requested Investor Email Alert updates.

* Required

*
*
Unsubscribe

Email Alert Sign Up Confirmation

SILENCE THERAPEUTICS logo
  • Privacy and cookie notice
  • Terms of use

© Silence Therapeutics 2020. 'Silence Therapeutics', 'Silence', the Silence logo, and AtuRNAi are all trademarks of Silence Therapeutics
Powered By Q4 Inc. 5.50.0.4 (opens in new window)